VaxGen Inc.-The 1st AIDS Vaccine in Phase 3 HumanTrials Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VaxGen Inc.-The 1st AIDS Vaccine in Phase 3 HumanTrials

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: glen who wrote (51)	7/7/1999 12:49:00 PM
From: Manfred Sondermann	Read Replies (1) of 250

Here is a cutting from the S1 filing: >We intend to use Genentech as our partner to manufacture and >distribute AIDSVAX. Genentech has exclusive options to manufacture >and market AIDSVAX on specified financial terms. What does that mean? Does that mean that Genentech is making the big money if AIDSVAX is successful? If so, how much would VXGN earn? 10 per cent, as usual? I wonder if VXGN only does the hard work and Genentech is the big winner?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next